Microparticles derived from drug-resistant cells regulate miR-503 and PYK2 to promote migration and invasion in breast cancer

Gong, J Luk, F Jaiswal, R

Bebawy, M

Permalink

Open Access

Copyright Clearance Process

This item is open access.

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Gong, J	en_US
dc.contributor.author	Luk, F	en_US
dc.contributor.author	Jaiswal, R https://orcid.org/0000-0002-8691-1352	en_US
dc.contributor.author	Bebawy, M https://orcid.org/0000-0003-2606-921X	en_US
dc.date.issued	2015-02-15	en_US
dc.identifier.citation	CLINICAL CANCER RESEARCH, 2015, 21	en_US
dc.identifier.issn	1078-0432	en_US
dc.identifier.uri	http://hdl.handle.net/10453/35340
dc.relation.ispartof	CLINICAL CANCER RESEARCH	en_US
dc.relation.isbasedon	10.1158/1557-3265.PMS14-PR08	en_US
dc.subject.classification	Oncology & Carcinogenesis	en_US
dc.title	Microparticles derived from drug-resistant cells regulate miR-503 and PYK2 to promote migration and invasion in breast cancer	en_US
dc.type	Conference Proceeding
utslib.citation.volume	21	en_US
utslib.for	1112 Oncology and Carcinogenesis	en_US
dc.location.activity	Orlando, FL
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Graduate School of Health
pubs.organisational-group	/University of Technology Sydney/Strength - CHT - Health Technologies
utslib.copyright.status	open_access
pubs.publication-status	Published	en_US
pubs.volume	21	en_US

Please use this identifier to cite or link to this item: